accessibility menu, dialog, popup

UserName
Brand Logo

Advanced Cell Culture Solutions for Cell Therapy

Ensure cell therapy safety with our consistent, high-quality raw materials, from premium (Pre-GMP) grade to GMP, and from discovery to clinic.

Product Benefits

Cytokines & Growth Factors

We offer a wide array of products designed to help with cell manufacturing of immune cells including T-cells, NK-cells, and Dendritic cells such as IL-2, 7, 15, 21. We also offer an increasingly large catalog of iPSC growth factors and differentiation factors including BMP-4, DLL4, VCAM-1, and many others. 

Benefit Icon

Cell Culture Media

Our product line includes chemically-defined, serum-free and xeno-free culture media for the differentiation and expansion of cells (including T, GDT, TILs, and NK-cells, as well as MSCs). Validated by real-world customer applications, our media enable robust and scalable in vitro cell culture.

Benefit Icon

Extracellular Matrix Proteins

Our extracellular matrix (ECM) proteins, including laminin, fibronectin and vitronectin, provide a superior matrix for hPSCs/MSCs, supporting every stage from early R&D to clinical translation with strict safety control.

Benefit Icon

CMC Process Solutions

Cell Therapy Bioprocessing

Our comprehensive cell therapy CMC process solutions provide end-to-end support for the development and manufacturing of advanced therapies, including T-cell, NK-cell, and iPSC-derived products. We also provide industry-standard bagged products, ensuring a closed, scalable, and compliant manufacturing process for clinical and commercial applications.

Learn More

T-Cell Therapy

We support scalable T-cell therapy CMC processes, including CAR-T and TILs, by providing reagents for activation, expansion, engineering, and GMP-compliant manufacturing to accelerate production.

NK-Cell Therapy

We offer comprehensive NK-cell CMC solutions, supporting manufacturing across diverse NK cell sources. Our products enable efficient cell selection, isolation, activation, CAR construction, and expansion to accelerate therapeutic development.

iPSC-Based Cell Therapy

We support iPSC-based cell therapy development by providing CMC solutions for differentiation into diverse cell types, including immune cells (T-cells, NK-cells, and macrophages), neurons, and islet cells, to accelerate scalable manufacturing.

MSC-based Cell Therapy

Our portfolio features a range of products, including culture media, matrix proteins, growth factors and cytokine detection kits, designed to deliver comprehensive support for the culture and quality control of mesenchymal stem cells(MSC) in research applications.

Product Features Image

Related Videos

Looking for a Resilient Supplier for Your CGT Development?

See how ACRO can help you.

iPSC-Derived Cell Therapy: Where Are We Now, and What’s Next

Next-generation IPSC cell therapy.

Related Documentation

Solutions for Immune Cell Therapy Development

Tools for immune cell therapies (CAR-T, TCR-T, TIL, CAR-NK).

Download

Special Topic on Deep Interpretation of GMP Product Quality

In-depth research into the global regulations and standards related to raw materials in the CGT industry, emphasizing aseptic assurance, quality control, global supply chain, and customs declaration requirements. 

Download

Comprehensive Quality Control Solutions for Biologics

Quality control for biologics, covering safety testing (endotoxin, mycoplasma) and process residuals (nucleic acids, enzymes, cell culture materials).

Download

CD8+ Single Positive T Cell Differentiation from Human Induced Pluripotent Stem Cell with a Feeder-Free System in vitro

Download

Scalable Stem Cell-derived Natural Killer Cell Differentiation in an In Vitro Feeder-free System

Download

Frequently Asked Questions

We source materials from qualified suppliers, conduct annual risk assessments, and perform visual and documentary checks (e.g., CoA, CoO, TSE/BSE declarations and animal-free statements). Key materials are validated before use.

Adopting GMP grade raw materials in early development can streamline the transition into later development stages.

Biological reagents like cytokines require rigorous validation through multiple batches to ensure consistency. Manufacturing under strict GMP controls, documented SOPs, and trained personnel ensure reliability. We assess multi-batch data and compare new batches to standards, maintaining lot-to-lot biological activity variability within 10-15%.

Overcoming Challenges from Discovery to the Clinic

Overcoming challenges from discovery to the clinic with innovation tools and solutions.

Learn more